Indiplon has been used in trials studying the treatment of Insomnia and Depression.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Hydrocodone | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Magnesium sulfate | The therapeutic efficacy of Indiplon can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Indiplon may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Mirtazapine | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Orphenadrine | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Pramipexole | Indiplon may increase the sedative activities of Pramipexole. |
| Ropinirole | Indiplon may increase the sedative activities of Ropinirole. |
| Rotigotine | Indiplon may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Indiplon. |
| Suvorexant | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Thalidomide | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Indiplon. |
| Sodium oxybate | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Ethanol | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Indiplon may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Indiplon is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Indiplon is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Indiplon is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Indiplon is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Indiplon is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Indiplon is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Indiplon is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Indiplon is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Indiplon is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Indiplon is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Indiplon is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Indiplon is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Indiplon is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Indiplon is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Indiplon is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Indiplon is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Indiplon is combined with Alaproclate. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Indiplon. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Indiplon. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Indiplon. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with Indiplon. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Indiplon. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Indiplon. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Indiplon. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Indiplon. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Indiplon. |
| Pizotifen | The risk or severity of CNS depression can be increased when Pizotifen is combined with Indiplon. |
| Dosulepin | The risk or severity of CNS depression can be increased when Dosulepin is combined with Indiplon. |
| Zopiclone | The risk or severity of adverse effects can be increased when Indiplon is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Indiplon. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Indiplon. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Indiplon. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Indiplon. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Indiplon. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Indiplon. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Indiplon. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Indiplon. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Indiplon. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Indiplon. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Indiplon. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Indiplon. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Indiplon. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Indiplon. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Indiplon. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Indiplon. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Indiplon. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Indiplon. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Indiplon. |
| Venlafaxine | The risk or severity of CNS depression can be increased when Venlafaxine is combined with Indiplon. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Indiplon. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Indiplon. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Indiplon. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Indiplon. |
| Valproic acid | The risk or severity of CNS depression can be increased when Valproic acid is combined with Indiplon. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Indiplon. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Indiplon. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Indiplon. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Indiplon. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Indiplon. |
| Olanzapine | The risk or severity of CNS depression can be increased when Olanzapine is combined with Indiplon. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Indiplon. |
| Protriptyline | The risk or severity of CNS depression can be increased when Protriptyline is combined with Indiplon. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Indiplon. |
| Clobazam | The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Indiplon. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Indiplon. |
| Clozapine | The risk or severity of CNS depression can be increased when Clozapine is combined with Indiplon. |
| Meprobamate | The risk or severity of CNS depression can be increased when Meprobamate is combined with Indiplon. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Indiplon. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Indiplon. |
| Sulpiride | The risk or severity of CNS depression can be increased when Sulpiride is combined with Indiplon. |
| Alprazolam | The risk or severity of CNS depression can be increased when Alprazolam is combined with Indiplon. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Indiplon. |